Literature DB >> 30791794

Sarcopenia and chronic liver diseases.

Ching-Sheng Hsu1,2, Jia-Horng Kao3,4,5,6.   

Abstract

INTRODUCTION: Sarcopenia is a syndrome characterized by progressive and generalized loss of skeletal muscle mass and strength, which is commonly associated with various chronic diseases, including chronic liver diseases. Growing lines of evidence indicate that sarcopenia not only correlates with the clinical outcomes and survival of patients undergoing liver transplant, but also serves as a prognostic factor for candidates of liver transplantation and patients with hepatocellular carcinoma. Areas covered: In this review, we conducted a narrative review and search of literature from PubMed, Ovid MEDLINE, and the Cochrane Library database up to August 2018. Studies relevant to the emerging data of sarcopenia and chronic liver diseases were examined and discussed. Expert commentary: Although sarcopenia has been shown to play a vital role in the outcomes of cirrhotic patients with or without liver transplant, its impact on non-cirrhotic patients remains unclear and deserves future research efforts. To develop an effective and practical measurement of sarcopenia has become an urgent issue in the management of patients with chronic liver diseases. ABBREVIATIONS: HCC: hepatocellular carcinoma; L3SMI: third lumbar vertebra skeletal muscle index; NAFLD: nonalcoholic fatty liver disease; VAT: visceral adipose tissue; PMA: psoas muscle area; LT: liver transplantation; AUC: area under the curve; LC: liver cirrhosis; SPPB: short physical performance battery; HU: Hounsfield units; ASM: appendicular skeletal muscle; SMI: skeletal muscle index; FLI: fatty liver index; PCLD: polycystic liver disease; DEXA: dual energy X-ray absorptiometry; BCAAs: branched-chain amino acids; BIA: bioelectrical impedance analysis; CT: computed tomography; OS: overall survival; CSA: cross-sectional area; NASH: nonalcoholic steatohepatitis; TPMT: transversal psoas muscle thickness; IMAC: intramuscular adipose tissue content; LDLT: living donor liver transplantation; PMI: psoas muscle mass index; PMTH: psoas muscle thickness by height; TPA: total psoas area; OLT: orthotopic liver transplantation; 6MWD: Six-minute walk distance; HRQOL: health-related quality of life; SMA: skeletal muscle area.

Entities:  

Keywords:  Sarcopenia; chronic disease; liver transplantation; muscle; prognosis

Mesh:

Year:  2018        PMID: 30791794     DOI: 10.1080/17474124.2018.1534586

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN: 1747-4124            Impact factor:   3.869


  24 in total

1.  Association of an Overhydrated State With the Liver Fibrosis and Prognosis of Cirrhotic Patients.

Authors:  Kyohei Kishino; Hirayuki Enomoto; Yoshihiro Shimono; Ei-Ichiro Moriwaki; Hiroki Nishikawa; Takashi Nishimura; Yoshinori Iwata; Hiroko Iijima; Shuhei Nishiguchi
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

2.  Editorial on "Is there any correlation between liver graft regeneration and recipient's pretransplant skeletal muscle mass?"

Authors:  Zhi-Jun Zhu
Journal:  Hepatobiliary Surg Nutr       Date:  2021-12       Impact factor: 7.293

Review 3.  European guideline on obesity care in patients with gastrointestinal and liver diseases - Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guideline.

Authors:  Stephan C Bischoff; Rocco Barazzoni; Luca Busetto; Marjo Campmans-Kuijpers; Vincenzo Cardinale; Irit Chermesh; Ahad Eshraghian; Haluk Tarik Kani; Wafaa Khannoussi; Laurence Lacaze; Miguel Léon-Sanz; Juan M Mendive; Michael W Müller; Johann Ockenga; Frank Tacke; Anders Thorell; Darija Vranesic Bender; Arved Weimann; Cristina Cuerda
Journal:  United European Gastroenterol J       Date:  2022-08-12       Impact factor: 6.866

4.  Sarcopenia and Frailty in Chronic Liver Damage: Common and Different Points.

Authors:  Hiroki Nishikawa; Kazunori Yoh; Hirayuki Enomoto; Yoshinori Iwata; Yoshiyuki Sakai; Kyohei Kishino; Yoshihiro Shimono; Naoto Ikeda; Tomoyuki Takashima; Nobuhiro Aizawa; Ryo Takata; Kunihiro Hasegawa; Takashi Koriyama; Yukihisa Yuri; Takashi Nishimura; Shuhei Nishiguchi; Hiroko Iijima
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

5.  Calf Circumference as a Useful Predictor of Sarcopenia in Patients With Liver Diseases.

Authors:  Hiroki Nishikawa; Kazunori Yoh; Hirayuki Enomoto; Yoshinori Iwata; Yoshiyuki Sakai; Kyohei Kishino; Yoshihiro Shimono; Naoto Ikeda; Tomoyuki Takashima; Nobuhiro Aizawa; Ryo Takata; Kunihiro Hasegawa; Takashi Koriyama; Yukihisa Yuri; Takashi Nishimura; Shuhei Nishiguchi; Hiroko Iijima
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

6.  Combined grip strength and calf circumference as a useful prognostic system in patients with liver diseases: a large cohort study.

Authors:  Hiroki Nishikawa; Kazunori Yoh; Hirayuki Enomoto; Takashi Nishimura; Shuhei Nishiguchi; Hiroko Iijima
Journal:  Ann Transl Med       Date:  2021-04

7.  Fatty Liver Index and Skeletal Muscle Density.

Authors:  Julie A Pasco; Sophia X Sui; Emma C West; Kara B Anderson; Pamela Rufus-Membere; Monica C Tembo; Natalie K Hyde; Lana J Williams; Zoe S J Liu; Mark A Kotowicz
Journal:  Calcif Tissue Int       Date:  2022-01-13       Impact factor: 4.000

8.  Walking Speed: Japanese Data in Chronic Liver Diseases.

Authors:  Hiroki Nishikawa; Hirayuki Enomoto; Kazunori Yoh; Yoshinori Iwata; Yoshiyuki Sakai; Kyohei Kishino; Naoto Ikeda; Tomoyuki Takashima; Nobuhiro Aizawa; Ryo Takata; Kunihiro Hasegawa; Noriko Ishii; Yukihisa Yuri; Takashi Nishimura; Hiroko Iijima; Shuhei Nishiguchi
Journal:  J Clin Med       Date:  2020-01-07       Impact factor: 4.241

9.  Nonalcoholic Fatty Liver Disease Is Associated With Low Skeletal Muscle Mass in Overweight/Obese Youths.

Authors:  Lucia Pacifico; Francesco Massimo Perla; Gianmarco Andreoli; Rosangela Grieco; Pasquale Pierimarchi; Claudio Chiesa
Journal:  Front Pediatr       Date:  2020-04-15       Impact factor: 3.418

10.  Sarcopenia Induced by Chronic Liver Disease in Mice Requires the Expression of the Bile Acids Membrane Receptor TGR5.

Authors:  Johanna Abrigo; Fabián Campos; Francisco Gonzalez; Francisco Aguirre; Andrea Gonzalez; Camila Huerta-Salgado; Sabrina Conejeros; Felipe Simon; Marco Arrese; Daniel Cabrera; Alvaro A Elorza; Claudio Cabello-Verrugio
Journal:  Int J Mol Sci       Date:  2020-10-25       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.